These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2023060)

  • 21. Influence of cholesterol oxides on endocytosis of cultured endothelial and smooth muscle cells.
    Peng SK; Hu B; Hsiao W; Morin R
    Artery; 1990; 17(2):84-95. PubMed ID: 2310306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.
    Véniant MM; Sullivan MA; Kim SK; Ambroziak P; Chu A; Wilson MD; Hellerstein MK; Rudel LL; Walzem RL; Young SG
    J Clin Invest; 2000 Dec; 106(12):1501-10. PubMed ID: 11120757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis.
    Watanabe T; Nishio K; Kanome T; Matsuyama TA; Koba S; Sakai T; Sato K; Hongo S; Nose K; Ota H; Kobayashi Y; Katagiri T; Shichiri M; Miyazaki A
    Circulation; 2008 Feb; 117(5):638-48. PubMed ID: 18212280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microdomains, Inflammation, and Atherosclerosis.
    Sorci-Thomas MG; Thomas MJ
    Circ Res; 2016 Feb; 118(4):679-91. PubMed ID: 26892966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotoxicity and arteriosclerosis due to contaminants of USP-grade cholesterol.
    Imai H; Werthessen NT; Taylor CB; Lee KT
    Arch Pathol Lab Med; 1976 Nov; 100(11):565-72. PubMed ID: 990067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice.
    Moore KJ; Kunjathoor VV; Koehn SL; Manning JJ; Tseng AA; Silver JM; McKee M; Freeman MW
    J Clin Invest; 2005 Aug; 115(8):2192-201. PubMed ID: 16075060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of oxidized lipoproteins in the pathogenesis of atherosclerosis.
    Kita T; Yokode M; Ishii K; Kume N; Nagano Y; Arai H; Otani H; Ueda Y; Hara S
    Clin Exp Pharmacol Physiol Suppl; 1992; 20():37-42. PubMed ID: 1446408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein degradation and cholesterol esterification in primary cell cultures of rabbit atherosclerotic lesions.
    Jaakkola O; Nikkari T
    Am J Pathol; 1990 Aug; 137(2):457-65. PubMed ID: 2201201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron loading increases cholesterol accumulation and macrophage scavenger receptor I expression in THP-1 mononuclear phagocytes.
    Kraml PJ; Klein RL; Huang Y; Nareika A; Lopes-Virella MF
    Metabolism; 2005 Apr; 54(4):453-9. PubMed ID: 15798950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uptake of dexamethasone incorporated into liposomes by macrophages and foam cells and its inhibitory effect on cellular cholesterol ester accumulation.
    Chono S; Morimoto K
    J Pharm Pharmacol; 2006 Sep; 58(9):1219-25. PubMed ID: 16945180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholesteryl ester accumulation in macrophages treated with oxidized low density lipoprotein.
    Ryu BH; Mao FW; Lou P; Gutman RL; Greenspan P
    Biosci Biotechnol Biochem; 1995 Sep; 59(9):1619-22. PubMed ID: 8520107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transport of cholesterol autoxidation products in rabbit lipoproteins.
    Peng SK; Phillips GA; Xia GZ; Morin RJ
    Atherosclerosis; 1987 Mar; 64(1):1-6. PubMed ID: 3593458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of human ACAT1 gene expression to promote the macrophage-derived foam cell formation by dexamethasone.
    Yang L; Yang JB; Chen J; Yu GY; Zhou P; Lei L; Wang ZZ; Cy Chang C; Yang XY; Chang TY; Li BL
    Cell Res; 2004 Aug; 14(4):315-23. PubMed ID: 15353128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
    Aviram M
    Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repair responses and tissue lipid after experimental injury to the artery.
    Björkerud S
    Ann N Y Acad Sci; 1976; 275():180-98. PubMed ID: 1070269
    [No Abstract]   [Full Text] [Related]  

  • 36. Adrenal cholesterol utilization.
    Kraemer FB
    Mol Cell Endocrinol; 2007 Feb; 265-266():42-5. PubMed ID: 17208360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atherogenic effect of oxidized products of cholesterol.
    Hubbard RW; Ono Y; Sanchez A
    Prog Food Nutr Sci; 1989; 13(1):17-44. PubMed ID: 2678267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Action of cholestane-3 beta,5 alpha,6 beta-triol on rats with particular reference to the aorta.
    Matthias D; Becker CH; Gödicke W; Schmidt R; Ponsold K
    Atherosclerosis; 1987 Feb; 63(2-3):115-24. PubMed ID: 3827976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of estrogens on macrophage foam cells: a potential target for the protective effects of estrogens on atherosclerosis.
    St Clair RW
    Curr Opin Lipidol; 1997 Oct; 8(5):281-6. PubMed ID: 9335952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smooth muscle cells and atherosclerosis.
    Stein O; Stein Y
    Curr Opin Lipidol; 1995 Oct; 6(5):269-74. PubMed ID: 8520848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.